Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00098969 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants(IRB 2004-535) | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Dec 17, 2012 | clinicaltrials |
| NCT01748019 | ST1968 Intravenous (Weekly) in Solid Tumors | completed | Phase 1 | 62 | sigma-tau i.f.r. S.p.A.INDUSTRY | 0 | Dec 12, 2012 | clinicaltrials |
| NCT00424645 |
| Voraxaze for Delayed Methotrexate Clearance |
| terminated |
| Phase 1 / Phase 2 |
| 3 |
| M.D. Anderson Cancer CenterOTHER |
| 1 |
| Dec 6, 2012 |
| clinicaltrials |
| NCT00349167 | PR-104 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | Proacta, IncorporatedINDUSTRY | 1 | Nov 30, 2012 | clinicaltrials |
| NCT00551005 | Etoposide and Celecoxib in Patients With Advanced Cancer | completed | Phase 1 | 58 | City of Hope Medical CenterOTHER | 0 | Nov 22, 2012 | clinicaltrials |
| NCT00840190 | A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies(Serenity) | completed | Phase 1 | 29 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 21, 2012 | clinicaltrials |
| NCT01568632 | Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Nov 21, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00551889 | Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer | completed | Phase 1 | 57 | City of Hope Medical CenterOTHER | 0 | Nov 12, 2012 | clinicaltrials |
| NCT00003132 | Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00004002 | PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00005990 | R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT01724320 | A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors | unknown | Phase 1 | 20 | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 2 | Nov 9, 2012 | clinicaltrials |
| NCT00003021 | Bizelesin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | The University of Texas Health Science Center at San AntonioOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT00697502 | Study of Capecitabine In Patients With Solid Tumors | completed | Phase 1 | 23 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00808184 | Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 Genotype | completed | Phase 4 | 25 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00609297 | Pain Control in Hospice Patients With Cancer-Related Pain | completed | — | 22 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 24, 2012 | clinicaltrials |
| NCT00005844 | Oxaliplatin in Treating Children With Advanced Solid Tumors | completed | Phase 1 | 26 | St. Jude Children's Research HospitalOTHER | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00495872 | Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor | completed | Phase 1 | 204 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00752011 | Phase I Study of TAS-106 in Combo With Carboplatin | completed | Phase 1 | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT01158079 | Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment | completed | Phase 1 | 7 | Alnylam PharmaceuticalsINDUSTRY | 2 | Oct 12, 2012 | clinicaltrials |
| NCT00093730 | BMS-599626 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 9 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00255749 | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer | completed | Phase 2 | 89 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00433407 | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | completed | N/A | 12 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00512798 | Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma | terminated | Phase 1 / Phase 2 | 47 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | completed | Phase 1 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT00003805 | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count | completed | Phase 3 | 859 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Sep 24, 2012 | clinicaltrials |
| NCT00004886 | MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00062231 | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer | terminated | N/A | 351 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00098943 | NGR-TNF in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT01286974 | A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors. | terminated | Phase 1 | 3 | AbbottINDUSTRY | 1 | Sep 21, 2012 | clinicaltrials |
| NCT00544336 | Family Quality of Life Among Families With a Member Who is a Cancer Patient | completed | — | 366 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 10, 2012 | clinicaltrials |
| NCT01016327 | Study of NMS-1116354 in Solid Tumors | terminated | Phase 1 | 15 | Nerviano Medical SciencesINDUSTRY | 1 | Sep 7, 2012 | clinicaltrials |
| NCT00666211 | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain | completed | Phase 3 | 98 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 6, 2012 | clinicaltrials |
| NCT01041235 | Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | completed | Phase 1 | 29 | Azaya Therapeutics, Inc.INDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00483457 | Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients | completed | — | 33 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT00482521 | CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment | completed | Phase 1 | 42 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT01521299 | A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors | withdrawn | Phase 1 | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Aug 28, 2012 | clinicaltrials |
| NCT00045019 | Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care | completed | — | 795 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Aug 27, 2012 | clinicaltrials |
| NCT00920595 | Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | CephalonINDUSTRY | 2 | Aug 16, 2012 | clinicaltrials |
| NCT00003708 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 32 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003709 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003710 | Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003712 | CCI-779 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 15 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00251407 | Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies | completed | Phase 1 | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT01098838 | Safety and Efficacy of LCL161 in Patients With Solid Tumors | completed | Phase 1 | 71 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 3, 2012 | clinicaltrials |
| NCT00502892 | Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | completed | Phase 1 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00509782 | Phase I Trial of ZIO-101 in Patients With Solid Tumors | completed | Phase 1 | 47 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00511017 | Doxercalciferol in Recurrent Pediatric Solid Tumors | terminated | Phase 1 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Dec 17, 2012source: clinicaltrials